Our Work
Latham Advises on Corteva and Vylor’s US$1.4 Billion Exchange Offers and Consent Solicitations
October 2, 2026
Capital Markets team represented the dealer managers in the transaction supporting Corteva’s completed spin-off of Vylor, the company’s advanced seed and genetics business.
Latham & Watkins represented the dealer managers in connection with Corteva, Inc. (NYSE: CTVA) and Vylor, Inc.’s US$1.4 billion exchange offers and consent solicitations. The transaction supports Corteva’s completed spin-off of Vylor, the company’s advanced seed and genetics business.
Byron Rooney, Global Vice Chair of Latham’s Capital Markets Practice, and partner Jenn Lan led the Latham team, with associates Jackie Stern and Jen Kim.